Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta‐Analysis of 22 Prospective Studies
Peter Willeit(Innsbruck Medical University), Rajiv Chowdhury(University of Cambridge), Manuel Mayr(King's College London), Jari A. Laukkanen(University of Eastern Finland), Reeta Gobin(University of Cambridge), Susmita Chowdhury(Genomics (United Kingdom)), Daniel F. Freitag(University of Cambridge), Emanuele Di Angelantonio(University of Cambridge)
Cited by 165
Related Papers
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Neurology|2017|2.3k
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
|Circulation Research|2010|1.5k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k